Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for VEGF Trap-Eye for the treatment of the…
High-quality hospitals deliver lower-cost care to trauma patients
High-quality hospitals deliver lower-cost care to trauma patients, according to a study published in the Annals of Surgery. The study found high-quality hospitals have death rates that are 34 percent lower, while…
Researcher finds antibiotic in Eastern Red Cedar tree effective against MRSA
Most people would never suspect that a “trash tree,” one with little economic value and often removed by farmers due to its ability to destroy farmland, could be the key to fighting…
Novartis FLUAD seasonal flu vaccine for older adults receives Health Canada approval
Provides enhanced vaccine immunogenicity and protection against flu strains not included in current vaccine Health Canada has approved FLUAD®, a Novartis seasonal flu vaccine for adults 65 years and older. Canadian seniors…
NanoString launches fixed-panel assay product for human molecular karyotyping
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product…
TransPharma completes ViaDor-GLP1 agonist Phase 1b trial for treatment of diabetes mellitus type II
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase…
Researchers find endothelial dysfunction can predict risk of coronary heart disease
A new study from the Libin Cardiovascular Institute at the University of Calgary’s Faculty of Medicine is shedding light on an underlying cause of heart disease. Published research led by UCalgary’s Dr….
Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer
Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced the initiation of the randomized Phase 2 portion of the trial of IPI-926 in combination with gemcitabine (also known as Gemzar®) in patients with previously untreated,…
Researchers discover biological pathway that transforms normal cells into aggressive tumors
A biological pathway that transforms normal cells into aggressive tumors has been discovered by researchers at Cleveland Clinic’s Lerner Research Institute. This research, led by Philip Howe, Ph.D., of the Cancer Biology…
Researchers to explore genomes of childhood cancers
In a project supported by Genome BC, a Vancouver pediatric pathologist at the BC Cancer Agency/University of British Columbia is leading the team that will explore the genomes (DNA) of four of…
Cancer-causing retrovirus prolongs survival of host cells
A cancer-causing retrovirus exploits key proteins in its host cells to extend the life of those cells, thereby prolonging its own survival and ability to spread, according to a new study by…
Epilepsy patients with low SES more likely to have poor quality of life
A newly published report reveals patients with epilepsy and low socioeconomic status (SES) are more likely to have uncontrolled seizures, drug-related side effects, and a lower overall quality of life. The study…
Vical extends relationship with U.S. NMRC for emerging disease vaccine platform
Vical Incorporated (Nasdaq:VICL) announced today that the company has extended its relationship with the U.S. Naval Medical Research Center (NMRC) to develop its platform technology for the rapid development and production of…
FDA approves OraSure’s rapid antibody test to detect HCV
OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that its OraQuick® HCV Rapid Antibody Test has now been approved by the U.S. Food and Drug Administration (“FDA”) for use in detecting HCV antibodies with…
Scientists believe plant extracts may have medical benefits to treat herpes
For centuries tansy has been used as a folk remedy, but now scientists from Britain and Spain believe the plant may have medical benefits after all, as a treatment for herpes. The…